Boundless Bio, Inc.
BOLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $22,580 | $33,673 | $49,254 |
| - Cash | $14,980 | $14,697 | $15,117 | $26,587 |
| + Debt | $46,707 | $49,510 | $48,574 | $47,632 |
| Enterprise Value | – | $57,393 | $67,130 | $70,299 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$310 | -$317 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13,569 | -$15,358 | -$17,024 | -$17,982 |
| % Margin | – | – | – | – |
| Net Income | -$13,879 | -$15,675 | -$15,758 | -$16,448 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.62 | -0.7 | -0.71 | -0.84 |
| % Growth | 11.4% | 1.4% | 15.5% | – |
| Operating Cash Flow | -$10,195 | -$11,829 | -$14,530 | -$15,563 |
| Capital Expenditures | -$15 | -$48 | -$59 | -$466 |
| Free Cash Flow | -$10,210 | -$11,877 | -$14,589 | -$16,029 |